[{"NetIncomeLoss_2_Q2_USD":-14589079.0,"GeneralAndAdministrativeExpense_1_Q2_USD":1949552.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":57116747.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":57582025.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":3145807.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_2_Q2_shares":269043.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-5856823.0,"AccruedLiabilitiesCurrentAndNoncurrent_0_Q2_USD":33910.0,"DividendsCommonStockCash_2_Q2_USD":0.0,"AssetsCurrent_0_Q2_USD":281808406.0,"DueToRelatedPartiesCurrent_0_Q2_USD":0.0,"UnrecognizedTaxBenefits_0_Q2_USD":0.0,"CommonStockSharesIssued_0_Q2_shares":90121794.0,"Assets_0_Q2_USD":297462629.0,"ShareBasedCompensation_2_Q2_USD":1583702.0,"StockIssuedDuringPeriodValueAcquisitions_1_Q2_USD":264565421.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":265426917.0,"GeneralAndAdministrativeExpense_2_Q2_USD":3414244.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"Liabilities_0_Q2_USD":11972307.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":273736820.0,"ResearchAndDevelopmentExpense_1_Q2_USD":6700862.0,"InterestCostsCapitalized_2_Q2_USD":54605.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":1149742.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-40468.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-30462.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_Q2_pure":0.65,"IncomeTaxExpenseBenefit_2_Q2_USD":164207.0,"IncomeTaxExpenseBenefit_1_Q2_USD":123782.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommonStockValue_0_Q2_USD":9012.0,"ForeignCurrencyTransactionGainLossBeforeTax_2_Q2_USD":-34806.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q2_USD":-27599.0,"IncreaseDecreaseInDueToRelatedPartiesCurrent_2_Q2_USD":33910.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":285876917.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q2_USD":1106457.0,"SharesIssuedPricePerShare_0_Q2_USD":6.97,"OtherAssetsCurrent_0_Q2_USD":64599.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.0072,"ProceedsFromIssuanceOrSaleOfEquity_2_Q2_USD":20450000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":10970160.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":6221240.0,"CommonStockSharesAuthorized_0_Q2_shares":430000000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-16830023.0,"ProceedsFromWarrantExercises_2_Q2_USD":20000000.0,"LiabilitiesCurrent_0_Q2_USD":11909588.0,"AccountsPayableCurrent_0_Q2_USD":5018089.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":273736820.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":8071586.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":450000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":167757.0,"RelatedPartyTransactionAmountsOfTransaction_2_Q2_USD":120697.0,"RelatedPartyTransactionAmountsOfTransaction_1_Q2_USD":73476.0,"AdditionalPaidInCapital_0_Q2_USD":313452616.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":285490322.0,"PrepaidInsurance_0_Q2_USD":3980461.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":62719.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":15654223.0,"NetIncomeLoss_1_Q2_USD":-8804658.0,"InterestIncomeExpenseNet_1_Q2_USD":-2863.0,"InterestIncomeExpenseNet_2_Q2_USD":-5662.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-8680876.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-14424872.0,"OperatingIncomeLoss_2_Q2_USD":-14384404.0,"OperatingIncomeLoss_1_Q2_USD":-8650414.0,"NotesPayableCurrent_0_Q2_USD":3556322.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":297462629.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":1118674.0,"OperatingExpenses_2_Q2_USD":14384404.0,"OperatingExpenses_1_Q2_USD":8650414.0,"IncreaseDecreaseInAccountsPayableTrade_2_Q2_USD":1043073.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.26,"ProfitLoss_2_Q2_USD":-14589079.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":5856823.0,"TaxesPayableCurrent_0_Q2_USD":189370.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-27971306.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":263190071.0,"RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_2_Q2_USD":6000.0,"CommonStockSharesOutstanding_0_Q2_shares":90121794.0,"AmortizationOfFinancingCosts_2_Q2_USD":5662.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.15,"AccruedProfessionalFeesCurrent_0_Q2_USD":280092.0,"Ticker":"PNT","CIK":"1811764","name":"POINT BIOPHARMA GLOBAL INC.","OfficialName":"POINT Biopharma Global Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"812904697.0","Country":"United States","Sector":"Consumer Durables","Industry":"Specialty Chemicals","Market":"NASDAQ","SP500":"nan","filed":"20210813"}]